Sulcal Widening in Schizophrenia Maps onto Sulcal Hubs and Energy-Synaptic Genes
Abstract
Schizophrenia (SZ) is increasingly framed as a disorder of large-scale brain networks emerging from atypical early neurodevelopment, yet how network architecture relates to cortical folding abnormalities remains unclear. Here, we introduce a sulcal morphological-centred network framework that integrates normative modelling of sulcal width with diffusion-derived structural connectivity and transcriptomic data in a large multisite cohort (n = 5,392; 377 SZ). Individuals with SZ showed widespread sulcal widening, affecting 30 of 40 sulci and most pronounced in frontal, temporal and occipital regions. Critically, sulci with higher degree centrality, reflecting greater embedding within the structural connectome, exhibited disproportionately greater widening in SZ (p spin = 0.02), indicating that network hubs of cortical folding are preferentially affected. Transcriptomic integration using partial least squares regression identified a single component explaining 56.5% of SZ-related sulcal widening variance (p perm = 0.041), implicating genes enriched for synaptic signalling and energy metabolism with adult cortical expression bias and genetic enrichment for cross-disorder psychiatric risk. In contrast, oppositely weighted genes showed prenatal expression bias and enrichment for rare disruptive variants in autism spectrum disorder. Together, these findings link aberrant sulcal morphology in SZ to the brain's network topology and molecular architecture, positioning cortical folding…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 5,392 participants or records.
Read the paper
Related studies
- Learning from First-Generation Qualitative Approaches in the IS Discipline: An Evolutionary View and Some Implications for Authors and Evaluators (PART 1/2)
- Commentary on the clinical and preclinical dosage limits of interstitially administered magnetic fluids for therapeutic hyperthermia based on current practice and efficacy models
- Prosthesis: New Technological Opportunities and Innovative Biomedical Devices
- The history and future of neural modeling for cochlear implants
- Ryanodine receptors: waking up from refractoriness
- Novel Transgenic Rabbit Model Sheds Light on the Puzzling Role of Matrix Metalloproteinase-12 in Atherosclerosis
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.